Compare Allbirds Inc (BIRD) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allbirds Inc vs Viatris Inc — how do they compare? Allbirds Inc trades at $2.6 (market cap $30.00M), while Viatris Inc trades at $16.28 (market cap $18.69B). The key difference: Viatris Inc is far larger — about 623× Allbirds Inc's market cap, and Viatris Inc pays a 2.95% dividend while Allbirds Inc pays none. Which is the better fit depends on your goals.
| BIRD | VTRS | |
|---|---|---|
Market Cap | $30.00M | $18.69B |
Sector | Consumer Cyclical | Health |
52-Week High | $16.99 | $17.86 |
52-Week Low | $2.21 | $9.49 |
Enterprise Value | $48.86M | $30.80B |
Dividend Yield | — | 2.95% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Allbirds Inc
Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
